SARS-CoV-2 vaccine alleviates disease burden and severity in liver transplant recipients even with low antibody titers

SARS-CoV-2 vaccine alleviates disease burden and severity in liver transplant recipients even with low antibody titers

Background and Aims:. We retrospectively assessed the clinical Pfizer’s mRNA SARS-CoV-2 BNT162b2 vaccination outcomes and the serologic impact on liver transplant (LT) recipients. Patients and Methods:. One hundred and sixty-seven LT cases followed between March 1, 2020 and September 25, 2021, and w...

Full description

Bibliographic Details
Main Authors: Abed Khalaileh, Ashraf Imam, Alaa Jammal, David Hakimian, Johnny Amer, Asher Shafrir, Yael Milgrom, Muhammad Massarwa, Wadi Hazou, Majd Khader, Rifaat Safadi
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2023-02-01
Series:Hepatology Communications
Online Access:http://journals.lww.com/10.1097/HC9.0000000000000025

Internet

http://journals.lww.com/10.1097/HC9.0000000000000025

Similar Items